Switch to:

Top Direct Holders

HolderPositionShares% of Shares
Outstanding
Report Date
Tisch Thomas JN/A378,4351.02%2013-01-09
Laurence A. TischN/A314,0760.85%2011-11-02
James S. TischN/A277,2200.75%2011-11-02
Tisch Daniel RN/A186,3570.5%2012-07-12
Mr. Sanj K. PatelN/A73,0310.2%2015-06-05
Mr. Thomas R. MalleyN/A46,9010.13%2011-12-12
Mr. Robert BazemoreN/A35,000less than 0.1%2015-06-05
Mr. Anthony G. Quinn, M.D. PhD, FRCPN/A32,637less than 0.1%2015-06-05
Glen WilliamsSVP, Technical Operations25,968less than 0.1%2015-06-05
Mr. Chris HeberligN/A24,390less than 0.1%2015-06-05

Insider Charts

Insider Transactions

Insider Position Date Buy/Sell Shares Shares Owned Following This (Direct & Indirect) Trade Price ($) Cost ($1000) Price Change
Since Trade (%)
Share Ownership Details
Williams GlenSVP, Technical Operations2015-06-08Sell12,91625,968$214.922775.911.0225,968 (Direct)
Williams GlenSVP, Technical Operations2015-05-06Sell1,666468$205.62342.616.04468 (Direct)
Quinn AnthonyEVP, CMO & Head of R&D2015-04-27Sell10,0005,637$1101100116.915,637 (Direct)
Quinn AnthonyEVP, CMO & Head of R&D2015-04-21Sell10,0005,637$1081080120.935,637 (Direct)
Quinn AnthonyEVP, CMO & Head of R&D2015-04-15Sell10,00015,637$1051050127.2415,637 (Direct)
Williams GlenSVP, Technical Operations2015-04-08Sell42,632468$96.084096.1148.33468 (Direct)
Quinn AnthonyEVP, CMO & Head of R&D2015-04-06Sell29,50315,637$93.762766.2154.4815,637 (Direct)
Heberlig ChrisSVP, Finance and Business Ops.2015-03-11Sell7,500390$103.17773.8131.27390 (Direct)
BOESS CARSTENSVP, CFO
(Click for the stocks that their CFOs have bought)
2015-02-17Sell42,2970$100.114234.4138.34Link
BAKER FELIXDirector, 10% Owner2015-01-07Buy1,000,00011,877,894$94.1994190153.32500 (Direct)
9,184,771 (See Footnotes(F9,F10,F11))
143,462 (See Footnotes(,))
219,050 (See Footnotes(F2,F10,F11))
177,463 (See Footnotes(F3,F10,F11))
67,729 (See Footnotes(F4,F10,F11))
112,740 (See Footnotes(F5,F10,F11))
1,748,315 (See Footnotes(F6,F10,F11))
223,864 (See Footnotes(F7,F10,F11))
BAKER JULIANDirector, 10% Owner2015-01-07Buy1,000,00011,878,414$94.1994190153.321,020 (Direct)
9,184,771 (See Footnotes(F9,F10,F11))
143,462 (See Footnotes(,))
219,050 (See Footnotes(F2,F10,F11))
177,463 (See Footnotes(F3,F10,F11))
67,729 (See Footnotes(F4,F10,F11))
112,740 (See Footnotes(F5,F10,F11))
1,748,315 (See Footnotes(F6,F10,F11))
223,864 (See Footnotes(F7,F10,F11))
Heberlig ChrisGroup Vice President, Finance2014-12-29Sell6,100304$91.14556161.8304 (Direct)
Patel Sanj KPresident & CEO
(Click for the stocks that their CEOs have bought)
2014-12-17Sell50,0001,031$88.854442.5168.541,031 (Direct)
BOESS CARSTENSVP, CFO2014-10-30Sell25,4040$80.12034.9197.88Link
Goldberg Mark AlanEVP, Medical & Reg. Strategy2014-09-19Sell790562$65.2451.5265.73562 (Direct)
Goldberg Mark AlanEVP, Medical & Reg. Strategy2014-09-17Sell13,579562$65.03883266.91562 (Direct)
Quinn AnthonyEVP, CMO & Head of R&D2014-09-02Sell10,00025,595$70.14701.4240.1825,595 (Direct)
Williams GlenSVP, Technical Operations2014-06-25Sell700266$108.0275.6120.89266 (Direct)
Quart Barry DDirector2014-06-20Sell1,3750$100137.5138.6Link
Quart Barry DDirector2014-06-17Sell1,0000$9090165.11Link
Quart Barry DDirector2014-06-12Sell1,0000$83.3183.3186.4Link
Goldberg Mark AlanEVP, Medical & Reg. Strategy2014-06-11Sell21,597459$801727.8198.25459 (Direct)
BOESS CARSTENSVP, CFO2014-05-16Sell9,9270$81.94813.4191.19Link
Quinn AnthonyEVP, CMO & Head of R&D2014-04-01Sell20,00015,524$83.531670.6185.6515,524 (Direct)
Heberlig ChrisGroup Vice President, Finance2014-03-12Sell7,670192$98.56756142.09192 (Direct)
BAKER JULIANDirector, 10% Owner2014-03-06Buy375,00010,792,664$105.7539656.3125.631,020 (Direct)
8,172,521 (See Footnotes(F8,F10,F11))
211,614 (See Footnotes(F9,F10,F11))
143,462 (See Footnotes(F1,F10))
206,800 (See Footnotes(F2,F10,F11))
165,213 (See Footnotes(F3,F10,F11))
55,479 (See Footnotes(F4,F10,F11))
100,490 (See Footnotes(F5,F10,F11))
1,736,065 (See Footnotes(F6,F10,F11))
BAKER FELIXDirector, 10% Owner2014-03-06Buy375,00010,792,144$105.7539656.3125.63500 (Direct)
8,172,521 (See Footnotes(F8,F10,F11))
211,614 (See Footnotes(F9,F10,F11))
143,462 (See Footnotes(F1,F10))
206,800 (See Footnotes(F2,F10,F11))
165,213 (See Footnotes(F3,F10,F11))
55,479 (See Footnotes(F4,F10,F11))
100,490 (See Footnotes(F5,F10,F11))
1,736,065 (See Footnotes(F6,F10,F11))
BOESS CARSTENSVP, CFO2014-02-18Sell9,9270$101.981012.4133.97Link
Patel Sanj KPresident & CEO2014-01-29Sell102,3001,317$88.129014.7170.771,031 (Direct)
286 (Held by Abbey Road Investment Group)
Goldberg Mark AlanSVP,Medical&Regulatory Affairs2013-12-03Sell7,000267$60.52423.6294.25267 (Direct)
BOESS CARSTENSVP, CFO2013-11-18Sell9,9270$55.09546.9333.11Link
Goldberg Mark AlanSVP,Medical&Regulatory Affairs2013-11-01Sell7,000267$49.96349.7377.58267 (Direct)
Goldberg Mark AlanSVP,Medical&Regulatory Affairs2013-10-01Sell7,000267$64.31450.2271.02267 (Direct)
BAKER FELIXDirector, 10% Owner2013-09-25Buy1,050,00010,417,144$56.6359461.5321.33500 (Direct)
7,806,552 (See Footnotes(F8,F10,F11))
202,583 (See Footnotes(F9,F10,F11))
143,462 (See Footnotes(F1,F10))
206,800 (See Footnotes(F2,F10,F11))
165,213 (See Footnotes(F3,F10,F11))
55,479 (See Footnotes(F4,F10,F11))
100,490 (See Footnotes(F5,F10,F11))
1,736,065 (See Footnotes(F6,F10,F11))
BAKER JULIANDirector, 10% Owner2013-09-25Buy1,050,00010,417,664$56.6359461.5321.331,020 (Direct)
7,806,552 (See Footnotes(F8,F10,F11))
202,583 (See Footnotes(F9,F10,F11))
143,462 (See Footnotes(F1,F10))
206,800 (See Footnotes(F2,F10,F11))
165,213 (See Footnotes(F3,F10,F11))
55,479 (See Footnotes(F4,F10,F11))
100,490 (See Footnotes(F5,F10,F11))
1,736,065 (See Footnotes(F6,F10,F11))
BOESS CARSTENSVP, CFO2013-08-21Sell14,4810$47.11682.2406.47Link
BOESS CARSTENSVP, CFO2013-08-16Sell4,3000$47.47204.1402.63Link
Patel Sanj KPresident & CEO2013-07-29Sell100,0001,317$48.024802396.881,031 (Direct)
286 (Held by Abbey Road Investment Group)
Heberlig ChrisVice President, Finance2013-07-16Sell2,5240$48.43122.2392.67Link
BOESS CARSTENSVP, CFO2013-07-11Sell13,2370$47.06622.9407.01Link
Patel Sanj KPresident & CEO2013-06-12Sell70,0001,317$40.652845.5486.961,031 (Direct)
286 (Held by Abbey Road Investment Group)
Patel Sanj KPresident & CEO2013-04-08Sell31,6051,317$49.681570.1380.271,031 (Direct)
286 (Held by Abbey Road Investment Group)
Patel Sanj KPresident & CEO2013-04-04Sell38,3951,317$50.911954.7368.671,031 (Direct)
286 (Held by Abbey Road Investment Group)
Goldberg Mark AlanSVP,Medical&Regulatory Affairs2013-04-01Sell4,4160$54.31239.8339.33Link
Goldberg Mark AlanSVP, Product Development2013-03-01Sell4,4170$50.76224.2370.06Link
Patel Sanj KPresident & CEO2013-02-21Sell70,0001,317$49.193443.3385.061,031 (Direct)
286 (Held by Abbey Road Investment Group)
Goldberg Mark AlanSVP, Product Development2013-02-01Sell4,4170$47.75210.9399.69Link
Quinn AnthonySVP, Chief Medical Officer2013-01-18Sell9,44715,035$50.08473.1376.4415,035 (Direct)
Quinn AnthonySVP, Chief Medical Officer2013-01-17Sell5,55315,035$50.07278376.5315,035 (Direct)
BOESS CARSTENSVP, CFO2013-01-16Sell9,9270$49.12487.6385.75Link
TISCH THOMAS JDirector2013-01-09Buy21,039751,995$47.531000402378,435 (Direct)
373,560 (Through trusts)
BAKER FELIXDirector, 10% Owner2013-01-04Buy859,7209,367,144$47.5340862.5402500 (Direct)
6,782,215 (See Footnotes(F8,F10,F11))
176,920 (See Footnotes(F9,F10,F11))
143,462 (See Footnotes(F1,F10))
206,800 (See Footnotes(F2,F10,F11))
165,213 (See Footnotes(F3,F10,F11))
55,479 (See Footnotes(F4,F10,F11))
100,490 (See Footnotes(F5,F10,F11))
1,736,065 (See Footnotes(F6,F10,F11))
BAKER JULIANDirector, 10% Owner2013-01-04Buy859,7209,367,664$47.5340862.54021,020 (Direct)
6,782,215 (See Footnotes(F8,F10,F11))
176,920 (See Footnotes(F9,F10,F11))
143,462 (See Footnotes(F1,F10))
206,800 (See Footnotes(F2,F10,F11))
165,213 (See Footnotes(F3,F10,F11))
55,479 (See Footnotes(F4,F10,F11))
100,490 (See Footnotes(F5,F10,F11))
1,736,065 (See Footnotes(F6,F10,F11))
Goldberg Mark AlanSVP, Product Development2013-01-02Sell4,4170$47.52209.9402.1Link
Heberlig ChrisVice President, Finance2012-12-19Sell4,0000$45.93183.7419.49Link
Patel Sanj KPresident & CEO2012-12-17Sell60,0001,317$46.212772.6416.341,031 (Direct)
286 (Held by Abbey Road Investment Group)
Patel Sanj KPresident & CEO2012-12-05Sell35,0001,317$48.921712.2387.741,031 (Direct)
286 (Held by Abbey Road Investment Group)
Patel Sanj KPresident & CEO2012-12-03Sell35,0001,317$49.341726.9383.581,031 (Direct)
286 (Held by Abbey Road Investment Group)
Heberlig ChrisVice President, Finance2012-10-17Sell4,0000$49.66198.6380.47Link
BOESS CARSTENSVP, CFO2012-10-16Sell9,9270$50.13497.6375.96Link
Patel Sanj KPresident & CEO2012-09-04Sell70,0001,317$49.473462.9382.311,031 (Direct)
286 (Held by Abbey Road Investment Group)
Heberlig ChrisVice President, Finance2012-09-04Sell1,0000$49.149.1385.95Link
Quinn AnthonySVP, Chief Medical Officer2012-07-27Sell7,50020,035$50.2376.5375.320,035 (Direct)
Quinn AnthonySVP, Chief Medical Officer2012-07-20Sell2,50020,035$50125377.220,035 (Direct)
BOESS CARSTENSVP, CFO2012-07-18Sell6,6180$48.82323.1388.73Link
BAKER JULIANDirector, 10% Owner2012-07-13Buy886,0008,507,944$41.236503.2479.131,020 (Direct)
5,942,594 (See Footnotes(F8,F10,F11))
156,821 (See Footnotes(F9,F10,F11))
143,462 (See Footnotes(F1,F10,F11))
206,800 (See Footnotes(F2,F10,F11))
165,213 (See Footnotes(F3,F10,F11))
55,479 (See Footnotes(F4,F10,F11))
100,490 (See Footnotes(F5,F10,F11))
1,736,065 (See Footnotes(F6,F10,F11))
BAKER FELIXDirector, 10% Owner2012-07-13Buy886,0008,507,424$41.236503.2479.13500 (Direct)
5,942,594 (See Footnotes(F8,F10,F11))
156,821 (See Footnotes(F9,F10,F11))
143,462 (See Footnotes(F1,F10,F11))
206,800 (See Footnotes(F2,F10,F11))
165,213 (See Footnotes(F3,F10,F11))
55,479 (See Footnotes(F4,F10,F11))
100,490 (See Footnotes(F5,F10,F11))
1,736,065 (See Footnotes(F6,F10,F11))
TISCH DANIEL R10% Owner2012-07-12Sell29,200399,019$46.751365.1410.37186,357 (Direct)
167,912 (Through trusts)
44,750 (Through family partnership)
TISCH THOMAS JDirector2012-07-12Buy73,000730,956$41.23007.6479.13378,435 (Direct)
352,521 (Through trusts)
TISCH DANIEL R10% Owner2012-07-11Sell10,000428,219$45.73457.3421.76215,557 (Direct)
167,912 (Through trusts)
44,750 (Through family partnership)
TISCH DANIEL R10% Owner2012-07-10Sell10,000438,219$45.23452.3427.53225,557 (Direct)
167,912 (Through trusts)
44,750 (Through family partnership)
AKKARAJU SRINIVASFormer Director2012-06-27Sell342,2781,026,832$39.7413602.1500.4
1,026,832 (See footnotes(,))
Quinn AnthonySVP, Chief Medical Officer2012-06-25Sell26,00020,035$40.651056.9486.9620,035 (Direct)

Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as Conversion of derivative security or Exercise of Options are not included. Insiders are only limited to Officers and/or Directors of the company.

"Shares" change (fifth column) and "Shares Owned Following This (Direct & Indirect)" transactions (sixth column) are split adjusted. The "Share Ownership Details" (last column) displayed data is as of reported.

To find out why GuruFocus thinks data on insider trade are interesting, please read:
Also See GuruFocus Insider Trade Screener:

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)

GuruFocus Premium Plus Membership

FEEDBACK